Virus-Specific Regulatory T Cells Ameliorate Encephalitis by Repressing Effector T Cell Functions from Priming to Effector Stages

PLoS Pathogens

Volumn 10, Issue 8, 2014, Pages

  Zhao, Jingxian ^a   Zhao, Jincun ^a   Perlman, Stanley ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD69 ANTIGEN; CHEMOKINE RECEPTOR CXCR3; EPITOPE; FINGOLIMOD; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CORONAVIRIDAE; EFFECTOR CELL; ENCEPHALITIS; FLOW CYTOMETRY; IMMUNE RESPONSE; MICROGLIA; MOUSE; NONHUMAN; REGULATORY T LYMPHOCYTE; ANIMAL; C57BL MOUSE; CORONAVIRIDAE INFECTION; DISEASE MODEL; IMMUNOLOGY; TRANSGENIC MOUSE; VIRUS ENCEPHALITIS;

ADOPTIVE TRANSFER; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CORONAVIRIDAE INFECTIONS; DISEASE MODELS, ANIMAL; ENCEPHALITIS, VIRAL; FLOW CYTOMETRY; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; T-LYMPHOCYTES, REGULATORY;

EID: 84938107770     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1004279     Document Type: Article

References (41)

1. Vignali DA, Collison LW, Workman CJ, (2008) How regulatory T cells work. Nat Rev Immunol 8: 523–532.
2. Lund JM, Hsing L, Pham TT, Rudensky AY, (2008) Coordination of early protective immunity to viral infection by regulatory T cells. Science 320: 1220–1224.
3. Ruckwardt TJ, Bonaparte KL, Nason MC, Graham BS, (2009) Regulatory T cells promote early influx of CD8+ T cells in the lungs of respiratory syncytial virus-infected mice and diminish immunodominance disparities. J Virol 83: 3019–3028.
4. Veiga-Parga T, Sehrawat S, Rouse BT, (2013) Role of regulatory T cells during virus infection. Immunol Rev 255: 182–196.
5. Lanteri MC, O'Brien KM, Purtha WE, Cameron MJ, Lund JM, et al. (2009) Tregs control the development of symptomatic West Nile virus infection in humans and mice. J Clin Invest 119: 3266–3277.
6. Suvas S, Azkur AK, Kim BS, Kumaraguru U, Rouse BT, (2004) CD4+CD25+ regulatory T cells control the severity of viral immunoinflammatory lesions. J Immunol 172: 4123–4132.
7. Trandem K, Anghelina D, Zhao J, Perlman S, (2010) Regulatory T cells inhibit T cell proliferation and decrease demyelination in mice chronically infected with a coronavirus. J Immunol 184: 4391–4400.
8. Anghelina D, Zhao J, Trandem K, Perlman S, (2009) Role of regulatory T cells in coronavirus-induced acute encephalitis. Virology 385: 358–367.
9. Veiga-Parga T, Suryawanshi A, Mulik S, Gimenez F, Sharma S, et al. (2012) On the role of regulatory T cells during viral-induced inflammatory lesions. J Immunol 189: 5924–5933.
10. Bedoya F, Cheng GS, Leibow A, Zakhary N, Weissler K, et al. (2013) Viral antigen induces differentiation of Foxp3+ natural regulatory T cells in influenza virus-infected mice. J Immunol 190: 6115–6125.
11. Suffia IJ, Reckling SK, Piccirillo CA, Goldszmid RS, Belkaid Y, (2006) Infected site-restricted Foxp3+ natural regulatory T cells are specific for microbial antigens. J Exp Med 203: 777–788.
12. Zhao J, Zhao J, Fett C, Trandem K, Fleming E, et al. (2011) IFN-gamma- and IL-10-expressing virus epitope-specific Foxp3(+) T reg cells in the central nervous system during encephalomyelitis. J Exp Med 208: 1571–1577.
13. Shafiani S, Dinh C, Ertelt JM, Moguche AO, Siddiqui I, et al. (2013) Pathogen-specific Treg cells expand early during mycobacterium tuberculosis infection but are later eliminated in response to Interleukin-12. Immunity 38: 1261–1270.
14. Johanns TM, Ertelt JM, Rowe JH, Way SS, (2010) Regulatory T cell suppressive potency dictates the balance between bacterial proliferation and clearance during persistent Salmonella infection. PLoS Pathog 6: e1001043.
15. Moon JJ, Dash P, Oguin TH, 3rdMcClaren JL, Chu HH, et al. (2011) Quantitative impact of thymic selection on Foxp3+ and Foxp3− subsets of self-peptide/MHC class II-specific CD4+ T cells. Proc Natl Acad Sci U S A 108: 14602–14607.
16. Belkaid Y, Oldenhove G, (2008) Tuning microenvironments: induction of regulatory T cells by dendritic cells. Immunity 29: 362–371.
17. Tang Q, Henriksen KJ, Bi M, Finger EB, Szot G, et al. (2004) In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J Exp Med 199: 1455–1465.
18. Tarbell KV, Petit L, Zuo X, Toy P, Luo X, et al. (2007) Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice. J Exp Med 204: 191–201.
19. Shafiani S, Tucker-Heard G, Kariyone A, Takatsu K, Urdahl KB, (2010) Pathogen-specific regulatory T cells delay the arrival of effector T cells in the lung during early tuberculosis. J Exp Med 207: 1409–1420.
20. Bergmann CC, Lane TE, Stohlman SA, (2006) Coronavirus infection of the central nervous system: host-virus stand-off. Nat Rev Microbiol 4: 121–132.
21. Campbell DJ, Koch MA, (2011) Phenotypical and functional specialization of FOXP3+ regulatory T cells. Nat Rev Immunol 11: 119–130.
22. Koch MA, Tucker-Heard G, Perdue NR, Killebrew JR, Urdahl KB, et al. (2009) The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat Immunol 10: 595–602.
23. Zhao J, Fett C, Pewe L, Zhao J, Perlman S, (2013) Development of transgenic mice expressing a coronavirus-specific public CD4 T cell receptor. J Immunol Methods 396: 56–64.
24. Liu MT, Chen BP, Oertel P, Buchmeier MJ, Armstrong D, et al. (2000) The T cell chemoattractant IFN-inducible protein 10 is essential in host defense against viral-induced neurologic disease. J Immunol 165: 2327–2330.
25. Brinkmann V, Billich A, Baumruker T, Heining P, Schmouder R, et al. (2010) Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis. Nat Rev Drug Discov 9: 883–897.
26. Beima KM, Miazgowicz MM, Lewis MD, Yan PS, Huang TH, et al. (2006) T-bet binding to newly identified target gene promoters is cell type-independent but results in variable context-dependent functional effects. J Biol Chem 281: 11992–12000.
27. Zhao J, Zhao J, Perlman S, (2012) Differential effects of IL-12 on Tregs and non-Treg T cells: roles of IFN-gamma, IL-2 and IL-2R. PLoS ONE 7: e46241.
28. Tang Q, Bluestone JA, (2006) Regulatory T-cell physiology and application to treat autoimmunity. Immunol Rev 212: 217–237.
29. Shevach EM, (2009) Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity 30: 636–645.
30. Sarween N, Chodos A, Raykundalia C, Khan M, Abbas AK, et al. (2004) CD4+CD25+ cells controlling a pathogenic CD4 response inhibit cytokine differentiation, CXCR-3 expression, and tissue invasion. J Immunol 173: 2942–2951.
31. Koenecke C, Lee CW, Thamm K, Fohse L, Schafferus M, et al. (2012) IFN-gamma production by allogeneic Foxp3+ regulatory T cells is essential for preventing experimental graft-versus-host disease. J Immunol 189: 2890–2896.
32. Oldenhove G, Bouladoux N, Wohlfert EA, Hall JA, Chou D, et al. (2009) Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection. Immunity 31: 772–786.
33. Korn T, Reddy J, Gao W, Bettelli E, Awasthi A, et al. (2007) Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat Med 13: 423–431.
34. Sun N, Grzybicki D, Castro R, Murphy S, Perlman S, (1995) Activation of astrocytes in the spinal cord of mice chronically infected with a neurotropic coronavirus. Virology 213: 482–493.
35. Marek-Trzonkowska N, Mysliwiec M, Dobyszuk A, Grabowska M, Techmanska I, et al. (2012) Administration of CD4+CD25highCD127- regulatory T cells preserves beta-cell function in type 1 diabetes in children. Diabetes Care 35: 1817–1820.
36. Tang Q, Lee K, (2012) Regulatory T-cell therapy for transplantation: how many cells do we need? Curr Opin Organ Transplant 17: 349–354.
37. Fleming JO, Trousdale MD, El-Zaatari F, Stohlman SA, Weiner LP, (1986) Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies. J Virol 58: 869–875.
38. Anghelina D, Pewe L, Perlman S, (2006) Pathogenic role for virus-specific CD4 T cells in mice with coronavirus-induced acute encephalitis. Am J Pathol 169: 209–222.
39. Pewe L, Zhou H, Netland J, Tangadu C, Olivares H, et al. (2005) A severe acute respiratory syndrome-associated coronavirus-specific protein enhances virulence of an attenuated murine coronavirus. J Virol 79: 11335–11342.
40. Castro RF, Perlman S, (1995) CD8+ T cell epitopes within the surface glycoprotein of a neurotropic coronavirus and correlation with pathogenicity. J Virol 69: 8127–8131.
41. Haring JS, Pewe LL, Perlman S, (2001) High-magnitude, virus-specific CD4 T-cell response in the central nervous system of coronavirus-infected mice. J Virol 75: 3043–3047.